DES0039951MA - - Google Patents
Info
- Publication number
- DES0039951MA DES0039951MA DES0039951MA DE S0039951M A DES0039951M A DE S0039951MA DE S0039951M A DES0039951M A DE S0039951MA
- Authority
- DE
- Germany
- Prior art keywords
- esters
- hours
- acetic acid
- acid
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- -1 alkyl amide Chemical class 0.000 claims 2
- 230000000694 effects Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1670536B2 (de) | Neue 2-Anilino-5-acylamino-pyrimidlne | |
| DE2166458A1 (de) | Metabolisch wirkendes mittel | |
| DE1518207B1 (de) | Verfahren zur Herstellung von neuen Phenylcyclopropanderivaten bzw. deren Salzen und quaternaeren Ammoniumverbindungen | |
| DE1960910B2 (de) | Benzylidenamino-oxyalkancarbonsäuren und deren Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DES0039951MA (enrdf_load_stackoverflow) | ||
| DE964326C (de) | Verfahren zur Herstellung von Derivaten des 4-Oxycumarins | |
| DE2446100B2 (de) | Phenoxyalkancarbonsäureamide von Thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE1294968B (de) | Phloroglucinverbindungen und Verfahren zu ihrer Herstellung | |
| DE2338350A1 (de) | Beta-(3,4-dialkanoyloxyphenyl)-lalanin-ester | |
| DE1291748B (de) | 1, 3-Dioxan-2-carbonsaeuren und deren Alkalisalze sowie Verfahren zu deren Herstellung | |
| DE1966215A1 (de) | Verfahren zur Herstellung von heterocyclischen Benzamiden | |
| DE1695785A1 (de) | Neue,substituierte 2-Aminomethylbenzofuranverbindungen und Verfahren zu deren Herstellung | |
| DE1493912C (de) | 2-(Naphthyl-l)-3-furyl-beziehungsweise -3-tetrahydrofuryl-propionsäure und deren Natriumsalze sowie Verfahren zu deren Herstellung | |
| DE1768787C3 (de) | (o-Carboxy-phenyl)-acetamidine, Verfahren zu deren Herstellung und (o-CarboxyphenyO-acetamidine enthaltende Präparate | |
| DE194051C (enrdf_load_stackoverflow) | ||
| DE2616657A1 (de) | Oxadiazolderivate und deren salze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen | |
| DE1036857B (de) | Verfahren zur Herstellung von 5-(Isobutyl)-5-aethyl-1-methylthiobarbitur-saeure und deren Salzen | |
| AT251585B (de) | Verfahren zur Herstellung von neuen 6,7-Dihydro-5H-pyrrolo-[3,4-d]-pyrimidinen | |
| AT213395B (de) | Verfahren zur Herstellung des neuen β-Hydroxybuttersäure-cyclohexylamids | |
| AT273954B (de) | Verfahren zur Herstellung des neuen Diäthyl-α-(2-dibenzofuranyl)-malonats | |
| DE1518207C (de) | Verfahren zur Herstellung von neuen Phenylcyclopropandenvaten bzw deren Salzen und quaternaren Ammomumverbin düngen | |
| DE2016057C3 (de) | Eckige Klammer auf (Thenyliden (2)- amino)-oxy] -alkylcarbonsäuren, deren Salze und Alkylester, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE2456685C3 (de) | Gluconsäure-2, 4, 6-trijodanilide, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel für Röntgenaufnahmen | |
| DE2015452A1 (de) | Amidosauren, Amidosauresalze und daraus gebildete Arzneimittel und Ver fahren zur Herstellung dieser Stoffe | |
| DE2120203A1 (en) | Phenylpropanolamine - para- chlorophenoxytates - sedatives giving increased awareness and learning capacity |